Skip to main content
Log in

Terminal differentiation of keratinocytes was damaged in type 2 diabetic mice

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Aims

Although skin manifestations are common in diabetic patients, its characteristics are poorly identified. This study explored the differentiation process of keratinocytes in type 2 diabetes mellitus (T2DM) in vivo.

Methods

Back skin of T2DM model KKAy/TaJcl mice (KKAy) and C57BL/6JJcl mice (control) aged 8 and 12 weeks was used. The mRNA expression of differentiation markers of keratinocytes was measured by quantitative real-time polymerase chain reaction (qRT-PCR). The expression of each marker in situ was examined immunohistochemically.

Results

KKAy mice showed hyperglycemia versus control mice. The histological findings showed increased thickness and structural impairment of epidermal tissue in KKAy mice. The qRT-PCR revealed that the expression of integrin beta 1 and keratin 14 in KKAy and control mice was identical. However, the expression of involucrin at 8 weeks, keratin 10 at 12 weeks, and filaggrin and loricrin at 8 and 12 weeks was decreased in KKAy mice. Immunohistochemical findings showed that filaggrin was markedly decreased in KKAy mice, though Ki-67 remained unchanged.

Conclusion

The terminal differentiation process was impaired in the diabetic skin, while keratinocyte proliferation was preserved. Damaged terminal differentiation of keratinocytes may contribute to impairment of the skin barrier function in diabetic dermatoses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

Not applicable.

Code availability

Not applicable.

References

  1. American Diabetes Association (2019) Cardiovascular disease and risk management: standards of medical care in diabetes-2019. Diabetes Care 42:S103–S123. https://doi.org/10.2337/dc19S010

    Article  Google Scholar 

  2. American Diabetes Association (2019) Microvascular complications and foot care: standards of medical care in diabetes-2019. Diabetes Care 42:S124–S138. https://doi.org/10.2337/dc19-s011

    Article  CAS  Google Scholar 

  3. Bertheim U, Engström-Laurent A, Hofer PÅ et al (2002) Loss of hyaluronan in the basement membrane zone of the skin correlates to the degree of stiff hands in diabetic patients. Acta Derm Venereol 82:329–334. https://doi.org/10.1080/000155502320624041

    Article  CAS  PubMed  Google Scholar 

  4. Brown SJ, McLean WHI (2012) One remarkable molecule: Filaggrin. J Invest Dermatol 132:751–762. https://doi.org/10.1038/jid.2011.393

    Article  CAS  PubMed  Google Scholar 

  5. Cai SCS, Chen H, Koh WP et al (2012) Filaggrin mutations are associated with recurrent skin infection in Singaporean Chinese patients with atopic dermatitis. Br J Dermatol 166:200–203. https://doi.org/10.1111/j.1365-2133.2011.10541.x

    Article  CAS  PubMed  Google Scholar 

  6. Candi E, Schmidt R, Melino G (2005) The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 6:328–340. https://doi.org/10.1038/nrm1619

    Article  CAS  PubMed  Google Scholar 

  7. Chatzigeorgiou A, Halapas A, Kalafatakis K, Kamper EF (2009) The use of animal models in the study of diabetes mellitus. In Vivo (Brooklyn) 23:245–258

    CAS  Google Scholar 

  8. Chen X, Lin W, Lu S et al (2010) Mechanistic study of endogenous skin lesions in diabetic rats. Exp Dermatol 19:1088–1095. https://doi.org/10.1111/j.1600-0625.2010.01137.x

    Article  CAS  PubMed  Google Scholar 

  9. Dash BC, Xu Z, Lin L et al (2018) Stem cells and engineered scaffolds for regenerative wound healing. Bioengineering 5:1–19. https://doi.org/10.3390/bioengineering5010023

    Article  CAS  Google Scholar 

  10. Falanga V (2005) Wound healing and its impairment in the diabetic foot. Lancet 366:1736–1743. https://doi.org/10.1016/S0140-6736(05)67700-8

    Article  PubMed  Google Scholar 

  11. Ferringer T, MillerIII F (2002) Cutaneous manifestations of diabetes mellitus. Dermatol Clin 20:483–492. https://doi.org/10.1016/s0733-8635(02)00018-9

    Article  PubMed  Google Scholar 

  12. Gilhar A, Ullmann Y, Karry R et al (2004) Ageing in human epidermis: the role of apoptosis, Fas and telomerase. Br J Dermatol 150:56–63. https://doi.org/10.1111/j.1365-2133.2004.05715.x

    Article  CAS  PubMed  Google Scholar 

  13. Li C, Hou S, Liu S et al (2017) The albumin-exendin-4 recombinant protein E2HSA improves glycemic control and β-cell function in spontaneous diabetic KKAy mice. BMC Pharmacol Toxicol 18:1–9. https://doi.org/10.1186/s40360-017-0143-8

    Article  CAS  Google Scholar 

  14. Lima AL, Illing T, Schliemann S, Elsner P (2017) Cutaneous manifestations of diabetes mellitus: a review. Am J Clin Dermatol 18:541–553. https://doi.org/10.1007/s40257-017-0275-z

    Article  PubMed  Google Scholar 

  15. Miyai M, Hamada M, Moriguchi T et al (2016) Transcription factor MafB coordinates epidermal keratinocyte differentiation. J Invest Dermatol 136:1848–1857. https://doi.org/10.1016/j.jid.2016.05.088

    Article  CAS  PubMed  Google Scholar 

  16. Muller LMAJ, Gorter KJ, Hak E et al (2005) Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 41:281–288. https://doi.org/10.1086/431587

    Article  CAS  PubMed  Google Scholar 

  17. Nakai K, Yoneda K, Ishihara Y et al (2011) Lipid peroxidation-induced VEGF expression in the skin of KKAy obese mice. Exp Dermatol 20:388–393. https://doi.org/10.1111/j.1600-0625.2010.01223.x

    Article  CAS  PubMed  Google Scholar 

  18. Neufang G, Furstenberger G, Heidt M et al (2001) Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci U S A 98:7629–7634. https://doi.org/10.1073/pnas.121574098

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Okano J, Kojima H, Katagi M et al (2016) Hyperglycemia induces skin barrier dysfunctions with impairment of epidermal integrity in non-wounded skin of type 1 diabetic mice. PLoS ONE 11:1–22. https://doi.org/10.1371/journal.pone.0166215

    Article  CAS  Google Scholar 

  20. Park HY, Kim JH, Jung M et al (2011) A long-standing hyperglycaemic condition impairs skin barrier by accelerating skin ageing process. Exp Dermatol 20:969–974. https://doi.org/10.1111/j.1600-0625.2011.01364.x

    Article  CAS  PubMed  Google Scholar 

  21. Rodgers KE, Ellefson DD, Espinoza T et al (2006) Expression of intracellular filament, collagen, and collagenase genes in diabetic and normal skin after injury. Wound Repair Regen 14:298–305. https://doi.org/10.1111/j.1743-6109.2006.00124.x

    Article  PubMed  Google Scholar 

  22. Sakai S, Endo Y, Ozawa N et al (2003) Characteristics of the epidermis and stratum corneum of hairless mice with experimentally induced diabetes mellitus. J Invest Dermatol 120:79–85. https://doi.org/10.1046/j.1523-1747.2003.12006.x

    Article  CAS  PubMed  Google Scholar 

  23. Sandilands A, Sutherland C, Irvine AD, McLean WHI (2009) Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 122:1285–1294. https://doi.org/10.1242/jcs.033969

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675. https://doi.org/10.1038/nmeth.2089

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Taylor KR, Costanzo AE, Jameson JM (2011) Dysfunctional γδ T cells contribute to impaired keratinocyte homeostasis in mouse models of obesity. J Invest Dermatol 131:2409–2418. https://doi.org/10.1038/jid.2011.241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Uchida K (2017) HNE as an inducer of COX-2. Free Radic Biol Med 111:169–172. https://doi.org/10.1016/j.freeradbiomed.2017.02.004

    Article  CAS  PubMed  Google Scholar 

  27. Yoneda K, Nakagawa T, Lawrence OT et al (2012) Interaction of the profilaggrin N-terminal domain with loricrin in human cultured keratinocytes and epidermis. J Invest Dermatol 132:1206–1214. https://doi.org/10.1038/jid.2011.460

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We give special thanks to Sayaka Nomura for excellent technical assistance. This study was supported by grants-in-aid from Fujita Health University.

Funding

This study was supported by grants-in-aid from Fujita Health University to AS.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Atsushi Suzuki.

Ethics declarations

Conflict of interest

TY and SH are employees of Nippon Menard Cosmetics Co., Ltd. Other authors do not have any financial or non-financial conflict of interest.

Ethical approval

The mice were handled ethically according to the Regulations for the Management of Laboratory Animals at Fujita Health University. The experimental protocol for the ethical use of these animals was approved by the Animal Care and Use Committee at Fujita Health University (Permit No.: M0271).

Consent to participate

All the authors have made a significant contribution to this manuscript, have seen and approved the final manuscript.

Consent for publication

All the authors have agreed to its submission to the “Molecular Biology Reports”.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takayanagi, T., Hirai, H., Asada, Y. et al. Terminal differentiation of keratinocytes was damaged in type 2 diabetic mice. Mol Biol Rep 49, 5875–5882 (2022). https://doi.org/10.1007/s11033-022-07367-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-022-07367-4

Keywords

Navigation